التفاصيل البيبلوغرافية
العنوان:
Neurodevelopmental outcome of preterm infants enrolled in myo-inositol randomized controlled trial
المؤلفون:
Susan R. Hintz , Denise Hug , Brenda B. Poindexter , Howard W. Kilbride , William Oh , Deanne E. Wilson-Costello , Michael B. Yang , Janell Fuller , Rosemary D. Higgins , Shawn Hirsch , Stephanie L. Merhar , Ann Marie Scorsone , Carol A. Cole , David K. Wallace , Kristi L. Watterberg , Amy K. Hutchinson , Graham E. Quinn , Kristin M. Zaterka-Baxter , Myriam Peralta-Carcelen , Martin S. Cogen , William R. Lucas , Richard J. Olson , Faruk H. Orge , Roy J. Heyne , Tarah T. Colaizy , Betty R. Vohr , Isabell B. Purdy , Conra Backstrom Lacy , Sara B. DeMauro , Dale L. Phelps , Michael W. Gaynon , John P Donahue , Tracy L. Nolen , Helen A. Mintz-Hittner , Heidi M. Harmon , Gary J. Myers , Andrea F. Duncan , Timothy W. Winter , Abhik Das , C. Michael Cotten , Yu-Guang He , Nathalie L. Maitre , Ricki F. Goldstein , Girija Natarajan , Kathryn M. Haider , Irena Tsui , Ira Adams-Chapman , Don L. Bremer
المصدر:
J Perinatol
بيانات النشر:
Springer Science and Business Media LLC, 2021.
سنة النشر:
2021
مصطلحات موضوعية:
medicine.medical_specialty , Pediatrics , Hearing loss , Gestational Age , Bayley Scales of Infant Development , Article , law.invention , Cerebral palsy , 03 medical and health sciences , chemistry.chemical_compound , Child Development , 0302 clinical medicine , Randomized controlled trial , law , 030225 pediatrics , medicine , Humans , Inositol , 030212 general & internal medicine , business.industry , Cerebral Palsy , Infant, Newborn , Obstetrics and Gynecology , Gestational age , medicine.disease , chemistry , Infant, Extremely Premature , Pediatrics, Perinatology and Child Health , Outcomes research , medicine.symptom , business , Retinopathy
الوصف:
OBJECTIVE: This study evaluates the 24 month follow up for the NICHD Neonatal Research Network (NRN) Inositol for Retinopathy Trial. STUDY DESIGN: Bayley Scales of Infants Development-III and a standardized neurosensory examination were performed in infants enrolled in the main trial. Moderate/severe NDI was defined as BSID-III Cognitive or Motor composite score
تدمد:
1476-5543 0743-8346
DOI:
10.1038/s41372-021-01018-5
URL الوصول:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::580bc3a28e830d8e1cdcf43790ac31f1 https://doi.org/10.1038/s41372-021-01018-5
Rights:
OPEN
رقم الانضمام:
edsair.doi.dedup.....580bc3a28e830d8e1cdcf43790ac31f1
قاعدة البيانات:
OpenAIRE